Waterloo Capital L.P. Boosts Stock Position in Chemed Co. (NYSE:CHE)

Waterloo Capital L.P. boosted its holdings in shares of Chemed Co. (NYSE:CHE) by 10.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,776 shares of the company’s stock after purchasing an additional 261 shares during the period. Waterloo Capital L.P.’s holdings in Chemed were worth $1,471,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Norges Bank bought a new stake in shares of Chemed during the 4th quarter valued at about $95,872,000. Raymond James Financial Inc. bought a new stake in Chemed during the 4th quarter valued at approximately $42,023,000. Principal Financial Group Inc. grew its holdings in shares of Chemed by 114.1% during the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company’s stock worth $39,554,000 after acquiring an additional 39,791 shares during the period. Segall Bryant & Hamill LLC purchased a new position in shares of Chemed during the 4th quarter worth approximately $12,880,000. Finally, Boston Trust Walden Corp raised its position in shares of Chemed by 10.0% in the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock worth $128,303,000 after acquiring an additional 22,105 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CHE. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th. Royal Bank of Canada boosted their target price on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Chemed Stock Performance

NYSE:CHE opened at $598.17 on Monday. The firm has a market cap of $8.76 billion, a P/E ratio of 30.23, a P/E/G ratio of 2.15 and a beta of 0.49. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $632.22. The firm has a 50-day simple moving average of $580.24 and a two-hundred day simple moving average of $567.98.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. Chemed’s payout ratio is currently 10.05%.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.